Literature DB >> 3784302

The effects of metabolic acidosis on bone formation and bone resorption in the rat.

J A Kraut, D R Mishler, F R Singer, W G Goodman.   

Abstract

Metabolic acidosis (MA) has been implicated in the pathogenesis of both osteomalacia and osteopenia. Alterations in the secretion of parathyroid hormone and in the metabolism of vitamin D may contribute to such skeletal changes. To minimize the influence of these factors, quantitative bone histology and measurements of bone formation using double tetracycline labeling were done in thyroparathyroidectomized (TPTX) rats with MA induced by ammonium chloride (TPTX-A), and in both non-acidotic TPTX (TPTX-C) and intact (C) controls. To evaluate the response of both cortical and trabecular bone to MA, histologic studies were done at three separate sites in the tibia, cortical bone from the mid-shaft, and trabecular bone from the epiphysis and from the metaphysis. Plasma pH was lower in TPTX-A, 7.24 +/- 0.10, than in either TPTX-C, 7.39 +/- 0.03, or C, 7.43 +/- 0.04, P less than 0.01, and urinary hydroxyproline excretion increased from 89.8 +/- 8.7 in TPTX-C to 150.2 +/- 25.9 micrograms/mg/creatinine in TPTX-A, P less than 0.01. Resorption surface at the epiphysis increased from 1.8 +/- 0.6% in TPTX-C to 4.0 +/- 1.6% in TPTX-A, P less than 0.05, values not different from those in C, 3.1 +/- 1.1%. Resorption surface was unchanged at other skeletal sites, but total bone volume at the metaphysis fell from 15.5 +/- 5.6% in TPTX-C to 9.0 +/- 4.3% in TPTX-A, P less than 0.05. Bone formation was reduced at each skeletal site in TPTX-A vs. TPTX-C, P less than 0.05 for all values, but histologic evidence of osteomalacia was not observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3784302     DOI: 10.1038/ki.1986.242

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  25 in total

1.  Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality.

Authors:  Astrid Starke; Alf Corsenca; Thomas Kohler; Johannes Knubben; Marius Kraenzlin; Daniel Uebelhart; Rudolf P Wüthrich; Brigitte von Rechenberg; Ralph Müller; Patrice M Ambühl
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-05       Impact factor: 8.237

Review 2.  Renal osteodystrophy for nonnephrologists.

Authors:  William G Goodman
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 3.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

4.  Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.

Authors:  Michal L Melamed; Edward J Horwitz; Mirela A Dobre; Matthew K Abramowitz; Liping Zhang; Yungtai Lo; William E Mitch; Thomas H Hostetter
Journal:  Am J Kidney Dis       Date:  2019-11-05       Impact factor: 8.860

Review 5.  Consequences and therapy of the metabolic acidosis of chronic kidney disease.

Authors:  Jeffrey A Kraut; Nicolaos E Madias
Journal:  Pediatr Nephrol       Date:  2010-06-05       Impact factor: 3.714

6.  Zinc bone loss in chronic renal failure and chronic metabolic acidosis.

Authors:  A Caldas; M J Richard; S Maniar; D Laouari; M Dechaux; A Favier; C Kleinknecht
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

7.  Chronic metabolic acidosis increases the serum concentration of 1,25-dihydroxyvitamin D in humans by stimulating its production rate. Critical role of acidosis-induced renal hypophosphatemia.

Authors:  R Krapf; R Vetsch; W Vetsch; H N Hulter
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

8.  Serum bicarbonate and bone mineral density in US adults.

Authors:  Wei Chen; Michal L Melamed; Matthew K Abramowitz
Journal:  Am J Kidney Dis       Date:  2014-08-29       Impact factor: 8.860

9.  Inhibition of osteoclast formation and function by bicarbonate: role of soluble adenylyl cyclase.

Authors:  Weidong Geng; Kathy Hill; Joseph E Zerwekh; Thomas Kohler; Ralph Müller; Orson W Moe
Journal:  J Cell Physiol       Date:  2009-08       Impact factor: 6.384

Review 10.  Treatment of metabolic acidosis in patients with CKD.

Authors:  Wei Chen; Matthew K Abramowitz
Journal:  Am J Kidney Dis       Date:  2013-08-07       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.